英夫利昔单抗诱导的自身免疫性肝炎在接受布地奈德和霉酚酸酯治疗的克罗恩病患者中出现 - Suppr

Suppr

超能文献

Infliximab-induced autoimmune hepatitis in Crohn's disease treated with budesonide and mycophenolate.

作者信息

Subramaniam K, Chitturi S, Brown M, Pavli P

出版信息

Inflamm Bowel Dis. 2011 Nov;17(11):E149-50. doi: 10.1002/ibd.21880. Epub 2011 Aug 30.

DOI:10.1002/ibd.21880

PMID:21987301

Abstract

摘要

相似文献

Infliximab-induced autoimmune hepatitis in Crohn's disease treated with budesonide and mycophenolate.

Inflamm Bowel Dis. 2011 Nov;17(11):E149-50. doi: 10.1002/ibd.21880. Epub 2011 Aug 30.

Infliximab-induced lupus-like syndrome associated with autoimmune hepatitis.

Inflamm Bowel Dis. 2008 May;14(5):723-5. doi: 10.1002/ibd.20293.

Autoimmune hepatitis during infliximab therapy for Crohn's disease: a case report.

J Crohns Colitis. 2011 Jun;5(3):253-5. doi: 10.1016/j.crohns.2010.12.007. Epub 2011 Feb 11.

Infliximab-induced autoimmune hepatitis with successful switch to adalimumab in a patient with Crohn's disease: the index case.

Dig Dis Sci. 2011 Nov;56(11):3386-8. doi: 10.1007/s10620-011-1748-1. Epub 2011 May 20.

Autoimmune hepatitis following treatment with infliximab for inflammatory bowel disease.

J Crohns Colitis. 2012 Jun;6(5):630-1. doi: 10.1016/j.crohns.2012.01.017. Epub 2012 Feb 9.

Autoimmune hepatitis induced by infliximab in a patient with Crohn's disease with no relapse after switching to adalimumab.

BioDrugs. 2010 Dec 14;24 Suppl 1:25-7. doi: 10.2165/11586210-000000000-00000.

Minocycline induced lupus and autoimmune hepatitis.

J Rheumatol. 2000 Jun;27(6):1567-8.

Drug-induced lupus and autoimmune hepatitis secondary to infliximab for psoriasis.

Australas J Dermatol. 2014 Feb;55(1):75-9. doi: 10.1111/ajd.12054. Epub 2013 May 8.

Adalimumab-induced autoimmune hepatitis in a patient with Crohn's disease.

Gastroenterol Hepatol. 2019 May;42(5):306-307. doi: 10.1016/j.gastrohep.2018.06.006. Epub 2018 Jul 17.

Adalimumab-induced lupus erythematosus in Crohn's disease patients previously treated with infliximab.

Gut. 2008 Apr;57(4):559; author reply 559-60.

引用本文的文献

Three-year outcomes of tumor necrosis factor alpha inhibitor therapy in rheumatoid arthritis patients with elevated liver enzymes.

World J Hepatol. 2025 Jul 27;17(7):108051. doi: 10.4254/wjh.v17.i7.108051.

Belimumab is a promising third-line treatment option for refractory autoimmune hepatitis.

JHEP Rep. 2020 May 29;2(4):100123. doi: 10.1016/j.jhepr.2020.100123. eCollection 2020 Aug.

Biologic and Checkpoint Inhibitor-Induced Liver Injury: A Systematic Literature Review.

Hepatol Commun. 2020 Jan 2;4(2):172-184. doi: 10.1002/hep4.1465. eCollection 2020 Feb.

Infliximab-induced autoimmune hepatitis requiring liver transplantation.

Clin Case Rep. 2019 Sep 27;7(11):2135-2139. doi: 10.1002/ccr3.2456. eCollection 2019 Nov.

Harmful Effects and Potential Benefits of Anti-Tumor Necrosis Factor (TNF)-α on the Liver.

Int J Mol Sci. 2018 Jul 27;19(8):2199. doi: 10.3390/ijms19082199.

Clinical Presentation and Outcomes of Autoimmune Hepatitis in Inflammatory Bowel Disease.

Dig Dis Sci. 2015 Oct;60(10):2873-80. doi: 10.1007/s10620-015-3699-4. Epub 2015 May 22.

Anti-tumour necrosis factor agent and liver injury: literature review, recommendations for management.

World J Gastroenterol. 2014 Dec 14;20(46):17352-9. doi: 10.3748/wjg.v20.i46.17352.

Liver Injury Secondary to Anti-TNF-Alpha Therapy in Inflammatory Bowel Disease: A Case Series and Review of the Literature.

Case Rep Gastrointest Med. 2014;2014:956463. doi: 10.1155/2014/956463. Epub 2014 Jan 19.

Hepatotoxicity of anti-TNF agents.

Dig Dis Sci. 2014 May;59(5):1070-1. doi: 10.1007/s10620-014-3109-3. Epub 2014 Mar 21.

Dig Dis Sci. 2013 Nov;58(11):3362-7. doi: 10.1007/s10620-013-2698-6. Epub 2013 May 5.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验